51674-77-2 Usage
General Description
Pyrido[3,2-d]pyrimidine, 4-chloro- is a chemical compound with the molecular formula C7H5ClN4. It is a heterocyclic aromatic compound that consists of a pyrido[3,2-d]pyrimidine ring system with a chlorine atom attached at the 4-position. Pyrido[3,2-d]pyrimidine, 4-chloro- is widely used in the pharmaceutical and agrochemical industries as a building block for the synthesis of various biologically active molecules and pesticides. It has also been studied for its potential antitumor and antiviral properties. Pyrido[3,2-d]pyrimidine, 4-chloro- is known for its role as an important intermediate in organic synthesis and has gained significant attention in the field of medicinal chemistry for drug discovery and development.
Check Digit Verification of cas no
The CAS Registry Mumber 51674-77-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,1,6,7 and 4 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 51674-77:
(7*5)+(6*1)+(5*6)+(4*7)+(3*4)+(2*7)+(1*7)=132
132 % 10 = 2
So 51674-77-2 is a valid CAS Registry Number.
InChI:InChI=1/C7H4ClN3/c8-7-6-5(10-4-11-7)2-1-3-9-6/h1-4H
51674-77-2Relevant articles and documents
Syntheses of Some Azolopyridopyrimidines
Petric, Andrej,Tisler, M.,Stanovnik, Branko
, p. 615 - 624 (1983)
Syntheses of isomeric azolopyridopyrimidines are described.As starting material the corresponding pyridopyrimidines were used.It could be established that in many cases a transformation of a functional group with the purpose to form an annelated five-membered ring proceeded with ring opening at the pyrimidine part.Subsequent ring closure with one carbon synthons gave then the desired tricyclic heterocycles. - Keywords: Cyclization with C-N and N-N bond formation; Tricyclic heterocyclic compounds
HETEROCYCLIC COMPOUNDS AND USES THEREOF
-
Paragraph 00648, (2013/03/26)
Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.
Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
-
, (2008/06/13)
-